J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M700009-JLR200 on July 3, 2007

Papers In Press, published online ahead of print October 1, 2007
J. Lipid Res., doi:10.1194/jlr.M700009-JLR200
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M700009-JLR200v1
48/10/2182    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moen, C. J. A.
Right arrow Articles by Rensen, P. C. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moen, C. J. A.
Right arrow Articles by Rensen, P. C. N.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 48, 2182-2192, October 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology

The Hyplip2 locus causes hypertriglyceridemia by decreased clearance of triglyceridesboxs

Corina J. A. Moen1,*, Aart P. Tholens*, Peter J. Voshol{dagger},§, Willeke de Haan{dagger}, Louis M. Havekes{dagger},§,**,{dagger}{dagger}, Peter Gargalovic§§, Aldons J. Lusis§§, Ko Willems van Dyk*,{dagger},**, Rune R. Frants*, Marten H. Hofker***,{dagger}{dagger}{dagger} and Patrick C. N. Rensen{dagger},§,**

* Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
{dagger} Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands
§ Netherlands Organization for Applied Scientific Research Quality of Life, Gaubius Laboratory, Leiden, The Netherlands
** Department of General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands
{dagger}{dagger} Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
§§ Departments of Microbiology, Immunology, and Molecular Genetics; Medicine; and Human Genetics, University of California Los Angeles, Los Angeles, CA
*** Department of Molecular Genetics, University Maastricht, Maastricht, The Netherlands
{dagger}{dagger}{dagger} Department of Pathology and Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands

boxs The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of one Table.

Published, JLR Papers in Press, July 3, 2007.

1 To whom correspondence should be addressed. e-mail: cmoen{at}lumc.nl

The Hyplip2 congenic mouse strain contains part of chromosome 15 from MRL/MpJ on the BALB/cJ background. Hyplip2 mice show increased plasma levels of cholesterol and predominantly triglycerides (TGs) and are susceptible to diet-induced atherosclerosis. This study aimed at elucidation of the mechanism(s) explaining the hypertriglyceridemia. Hypertriglyceridemia can result from increased intestinal or hepatic TG production and/or by decreased LPL-mediated TG clearance. The intestinal TG absorption and chylomicron formation were studied after intravenous injection of Triton WR1339 and an intragastric load of olive oil containing glycerol tri[3H]oleate. No difference was found in intestinal TG absorption. Moreover, the hepatic VLDL-TG production rate and VLDL particle production, after injection of Triton WR1339, were also not affected. To investigate the LPL-mediated TG clearance, mice were injected intravenously with glycerol tri[3H]oleate-labeled VLDL-like emulsion particles. In Hyplip2 mice, the particles were cleared at a decreased rate (half-life of 25 ± 6 vs. 11 ± 2 min; P < 0.05) concomitant with a decreased uptake of emulsion TG-derived 3H-labeled fatty acids by the liver and white adipose tissue. The increased plasma TG levels in Hyplip2 mice do not result from an enhanced intestinal absorption or increased hepatic VLDL production but are caused by decreased LPL-mediated TG clearance.

Supplementary key words congenic mice • lipoproteins • lipoprotein lipase • triglyceride hydrolysis • lipoprotein clearance


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.